|
|
|
| home > white papers > Translating Cancer Genomics Into A Personalised Approach For Cancer Patients - PRA Health Sciences (PRA) |
|
|
 WHITE PAPERS |
|
PRA Health Sciences (PRA)
|
|
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
|
|
Over the past few decades, the approach to prevention, diagnosis and
treatment of cancer has radically shifted from organ-based to
morphology-based and most recently, to genetics-based. Personalized or
precision medicine (tailoring a treatment for a patient’s particular
disease at a precise time point) is being performed every day at
different levels in the clinical setting.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
FlyPharma Conference Europe: New dates and location announced
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022. Taking
place in Leipzig, Germany on 19-21 September, FlyPharma Europe will
bring together a global audience of (bio)pharma logistics professionals
to discuss and debate the latest supply chain challenges and industry
best practices.
More info >> |
|
 |
White Papers |
 |
|
Exploring Protein Stability by nanoDSF
NanoTemper Technologies GmbH
nanoDSF determines thermal and chemical protein stability with
ultra-high resolution and with unmatched reproducibility. The detection
of the intrinsic tryptophan and tyrosin fluorescence enables
measurements at close-to-native conditions in any buffer, even in the
presence of detergents. nanoDSF is applied in antibody engineering,
membrane protein research, formulation and quality control.
More info >> |
|
|
|
